{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:08:12Z","timestamp":1791256092371,"version":"4.1.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.22897","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:31:05Z","timestamp":1603899065000},"page":"e2022897","source":"Crossref","is-referenced-by-count":11,"title":["National Poison Center Calls Before vs After Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland"],"prefix":"10.1001","volume":"3","author":[{"given":"Adrian","family":"Martinez-De la Torre","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Weiler","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland"},{"name":"National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic Stefan","family":"Br\u00e4m","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Allemann","sequence":"additional","affiliation":[{"name":"Swiss Association of Pharmacists, Bern-Liebefeld, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Kupferschmidt","sequence":"additional","affiliation":[{"name":"National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Burden","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"issue":"3","key":"zoi200765r1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/bcpt.2018.123.issue-3","article-title":"Trends in use of paracetamol in the Nordic countries.","volume":"123","author":"Wastesson","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"zoi200765r2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12913-017-2086-6","article-title":"Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims.","volume":"17","author":"Wertli","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"zoi200765r3","first-page":"765","article-title":"Assessment and treatment of acetaminophen overdose.","volume":"10","author":"Lewis","year":"1991","journal-title":"Clin Pharm"},{"issue":"2","key":"zoi200765r4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00045391-200007020-00011","article-title":"Paracetamol: past, present, and future.","volume":"7","author":"Prescott","year":"2000","journal-title":"Am J Ther"},{"issue":"2","key":"zoi200765r5","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update.","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"zoi200765r6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: not as safe as we thought? a systematic literature review of observational studies.","volume":"75","author":"Roberts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"zoi200765r7","doi-asserted-by":"publisher","first-page":"h1225","DOI":"10.1136\/bmj.h1225","article-title":"Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.","volume":"350","author":"Machado","year":"2015","journal-title":"BMJ"},{"key":"zoi200765r8","doi-asserted-by":"publisher","first-page":"l6693","DOI":"10.1136\/bmj.l6693","article-title":"Paracetamol for pain in adults.","volume":"367","author":"Saragiotto","year":"2019","journal-title":"BMJ"},{"issue":"10090","key":"zoi200765r9","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis.","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"zoi200765r10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/ejp.649","article-title":"Overview review: comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.","volume":"19","author":"Moore","year":"2015","journal-title":"Eur J Pain"},{"issue":"2","key":"zoi200765r11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2125.2010.03819.x","article-title":"Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity.","volume":"71","author":"Craig","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"zoi200765r13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s11606-012-2096-3","article-title":"Risk of unintentional overdose with non-prescription acetaminophen products.","volume":"27","author":"Wolf","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi200765r14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/bcpt.2018.122.issue-6","article-title":"Availability of paracetamol sold over the counter in Europe: a descriptive cross-sectional international survey of pack size restriction.","volume":"122","author":"Morthorst","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"zoi200765r15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/pubmed\/fdh200","article-title":"Restricting paracetamol in the United Kingdom to reduce poisoning: a systematic review.","volume":"27","author":"Morgan","year":"2005","journal-title":"J Public Health (Oxf)"},{"issue":"1","key":"zoi200765r16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/pubmed\/fdh216","article-title":"Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study.","volume":"27","author":"Morgan","year":"2005","journal-title":"J Public Health (Oxf)"},{"key":"zoi200765r17","doi-asserted-by":"publisher","first-page":"f403","DOI":"10.1136\/bmj.f403","article-title":"Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses.","volume":"346","author":"Hawton","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"zoi200765r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040152","article-title":"Does restricting pack size of paracetamol (acetaminophen) reduce suicides?","volume":"4","author":"Buckley","year":"2007","journal-title":"PLoS Med"},{"issue":"1","key":"zoi200765r19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6904-10-6","article-title":"Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market.","volume":"10","author":"Corcoran","year":"2010","journal-title":"BMC Clin Pharmacol"},{"issue":"3","key":"zoi200765r20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/15563650.2017.1359619","article-title":"Increased acetaminophen related calls to Finnish PIC better reflect acetaminophen sales than serious poisonings.","volume":"56","author":"Parry","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"zoi200765r22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jclinepi.2014.12.018","article-title":"Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations.","volume":"68","author":"Jandoc","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"zoi200765r23","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements.","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad Pediatr"},{"issue":"1","key":"zoi200765r24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biomet\/57.1.1","article-title":"Inference about the change-point in a sequence of random variables.","volume":"57","author":"Hinkley","year":"1970","journal-title":"Biometrika"},{"key":"zoi200765r26","doi-asserted-by":"publisher","first-page":"h2221","DOI":"10.1136\/bmj.h2221","article-title":"Paracetamol should remain the first line option for persistent pain.","volume":"350","author":"Veal","year":"2015","journal-title":"BMJ"},{"issue":"9954","key":"zoi200765r27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(14)60805-9","article-title":"Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial.","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"zoi200765r28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ejhpharm-2016-000952","article-title":"Paracetamol and pain: the kiloton problem.","volume":"23","author":"Moore","year":"2016","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"zoi200765r29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction.","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"16","key":"zoi200765r30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","article-title":"Acetaminophen toxicity in an urban county hospital.","volume":"337","author":"Schi\u00f8dt","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi200765r31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF03169171","article-title":"Pack-size legislation reduces severity of paracetamol overdoses in Ireland.","volume":"175","author":"Donohoe","year":"2006","journal-title":"Ir J Med Sci"},{"issue":"5","key":"zoi200765r32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bcp.2006.62.issue-5","article-title":"Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland.","volume":"62","author":"Bateman","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"zoi200765r33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bcp.12957","article-title":"Usage patterns of paracetamol in France.","volume":"82","author":"Duong","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"zoi200765r12","unstructured":"National Institute for Health and Care Excellence. Chronic pain in over 16s: assessment and management. Published online August 3, 2020. Accessed August 3, 2020. https:\/\/www.nice.org.uk\/guidance\/gid-ng10069\/documents\/draft-guideline"},{"key":"zoi200765r21","unstructured":"Tox Info Suisse. Annual report 2018. Accessed March 3, 2020. https:\/\/toxinfo.ch\/customer\/files\/743\/9192596_TOX_Jahresbericht_2018_E_Web.pdf"},{"key":"zoi200765r25","unstructured":"US Food and Drug Administration. Recommendations for FDA interventions to decrease the occurrence of acetaminophen hepatotoxicity. Published February 26, 2008. Accessed September 29, 2020. https:\/\/www.litigationandtrial.com\/files\/2011\/12\/2009-4429b1-02-FDA.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2772304\/martinezde_la_torre_2020_oi_200765_1603224433.924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:31:22Z","timestamp":1603899082000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2772304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.22897","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]}}}